- Home
- CUE vs ATPC Comparison
CUE vs ATPC Comparison
Compare CUE & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- ATPC
- Stock Information
- Founded
- CUE 2014
- ATPC 2016
- Country
- CUE United States
- ATPC Malaysia
- Employees
- CUE N/A
- ATPC N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- ATPC Medical/Nursing Services
- Sector
- CUE Health Care
- ATPC Health Care
- Exchange
- CUE Nasdaq
- ATPC Nasdaq
- Market Cap
- CUE 56.1M
- ATPC 58.5M
- IPO Year
- CUE 2018
- ATPC N/A
- Fundamental
- Price
- CUE $0.86
- ATPC N/A
- Analyst Decision
- CUE Strong Buy
- ATPC
- Analyst Count
- CUE 2
- ATPC 0
- Target Price
- CUE $3.00
- ATPC N/A
- AVG Volume (30 Days)
- CUE 220.6K
- ATPC 25.1K
- Earning Date
- CUE 11-13-2025
- ATPC 11-13-2025
- Dividend Yield
- CUE N/A
- ATPC N/A
- EPS Growth
- CUE N/A
- ATPC N/A
- EPS
- CUE N/A
- ATPC N/A
- Revenue
- CUE $8,286,000.00
- ATPC $1,445,601.00
- Revenue This Year
- CUE N/A
- ATPC N/A
- Revenue Next Year
- CUE N/A
- ATPC N/A
- P/E Ratio
- CUE N/A
- ATPC N/A
- Revenue Growth
- CUE N/A
- ATPC 4.90
- 52 Week Low
- CUE $0.54
- ATPC $0.90
- 52 Week High
- CUE $1.99
- ATPC $2.93
- Technical
- Relative Strength Index (RSI)
- CUE 58.69
- ATPC N/A
- Support Level
- CUE $0.71
- ATPC N/A
- Resistance Level
- CUE $0.73
- ATPC N/A
- Average True Range (ATR)
- CUE 0.04
- ATPC 0.00
- MACD
- CUE 0.01
- ATPC 0.00
- Stochastic Oscillator
- CUE 95.92
- ATPC 0.00
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.